Dipeptidyl Peptidase 4 Inhibitor [EPC]

Known as: Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, Dipeptidyl-Peptidase IV Inhibitor, DPP-4 Inhibitor 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2018
0102020062018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
IMPORTANCE Previous trial results have suggested that dipeptidyl peptidase 4 inhibitor (DPP4i) use might increase heart failure… (More)
  • table 1
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2013
2013
There have been few reports concerning the trends in antidiabetic drug use in Japan. In 2009, a dipeptidyl peptidase-4 inhibitor… (More)
Is this relevant?
2013
2013
BACKGROUND Dipeptidyl peptidase-4 (DPP-4) inhibitor is a new anti-diabetic drug for type-2 diabetes mellitus patients. Despite… (More)
Is this relevant?
2013
2013
AIMS/HYPOTHESIS Glucagon-like peptide-1 (GLP-1) exerts beneficial effects on the cardiovascular system. Here, we examined the… (More)
  • table 1
  • table 2
Is this relevant?
2013
2013
AIM To assess the efficacy, safety and dose-response relationship of once-daily teneligliptin, a novel dipeptidyl peptidase-4… (More)
Is this relevant?
2013
2013
Studies have shown that dipeptidyl peptidase-4 (DPP4) inhibitors stimulate insulin secretion and increase beta cell mass in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2012
Highly Cited
2012
OBJECTIVES The aim of this study was to investigate the antiatherogenic effects of the dipeptidyl peptidase-4 inhibitor, des… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
AIM Enhancing the physiologic actions of the endogenous incretin hormones, glucagon-like peptide-1 and glucose-dependent… (More)
Is this relevant?
2008
2008
Dipeptidyl peptidase-4 (DPP-4) inhibitors improve glycemic control in patients with type 2 diabetes by increasing plasma active… (More)
  • figure 1
  • table 2
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVE To examine the efficacy and safety of once-daily oral sitagliptin as monotherapy in patients with type 2 diabetes… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?